Fierce Biotech February 2, 2024
For the second time just this week, an artificial intelligence-powered tool aimed at improving cervical cancer screening is taking center stage.
This time around, Hologic is the star of the show. Its Genius digital diagnostics system has earned FDA clearance, the company announced late Thursday, allowing it to be used in the U.S. to aid in cervical cancer detection.
The system is equipped with both imaging technology and deep learning AI to analyze Pap smear samples. Traditionally, after being sent off to a lab for interpretation, samples are transferred to a glass slide for a cytologist or pathologist to examine under a microscope; Hologic’s system, in contrast, creates a digital copy of the slide and automatically flags any potential signs...
Today's Sponsors
Today's Sponsor